BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32044367)

  • 1. Graphene oxide based functionalized chitosan polyelectrolyte nanocomposite for targeted and pH responsive drug delivery.
    Anirudhan TS; Chithra Sekhar V; Athira VS
    Int J Biol Macromol; 2020 May; 150():468-479. PubMed ID: 32044367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-grafted-poly(methacrylic acid)/graphene oxide nanocomposite as a pH-responsive de novo cancer chemotherapy nanosystem.
    Abbasian M; Roudi MM; Mahmoodzadeh F; Eskandani M; Jaymand M
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1871-1879. PubMed ID: 30017982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of stimuli-responsive chitosan nanocomposites via RAFT copolymerization for doxorubicin delivery.
    Hosseinzadeh S; Hosseinzadeh H; Pashaei S; Khodaparast Z
    Int J Biol Macromol; 2019 Jan; 121():677-685. PubMed ID: 30339997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Layer-by-layer modification of magnetic graphene oxide by chitosan and sodium alginate with enhanced dispersibility for targeted drug delivery and photothermal therapy.
    Xie M; Zhang F; Peng H; Zhang Y; Li Y; Xu Y; Xie J
    Colloids Surf B Biointerfaces; 2019 Apr; 176():462-470. PubMed ID: 30682619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems.
    Pan Q; Lv Y; Williams GR; Tao L; Yang H; Li H; Zhu L
    Carbohydr Polym; 2016 Oct; 151():812-820. PubMed ID: 27474628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
    Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
    Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile preparation of antibacterial chitosan/graphene oxide-Ag bio-nanocomposite hydrogel beads for controlled release of doxorubicin.
    Rasoulzadehzali M; Namazi H
    Int J Biol Macromol; 2018 Sep; 116():54-63. PubMed ID: 29705108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe
    Gerami SE; Pourmadadi M; Fatoorehchi H; Yazdian F; Rashedi H; Nigjeh MN
    Int J Biol Macromol; 2021 Mar; 173():409-420. PubMed ID: 33454326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Characterization of Chitosan-Graphene Oxide Nanocomposites for the Delivery of Proanthocyanidins.
    Figueroa T; Aguayo C; Fernández K
    Int J Nanomedicine; 2020; 15():1229-1238. PubMed ID: 32110019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Development of Graphene Oxide Nanoparticle/Chitosan Hybrids Showing pH-Sensitive Surface Charge-Reversible Ability for Efficient Intracellular Doxorubicin Delivery.
    Zhao X; Wei Z; Zhao Z; Miao Y; Qiu Y; Yang W; Jia X; Liu Z; Hou H
    ACS Appl Mater Interfaces; 2018 Feb; 10(7):6608-6617. PubMed ID: 29368916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan, magnetite, silicon dioxide, and graphene oxide nanocomposites: Synthesis, characterization, efficiency as cisplatin drug delivery, and DFT calculations.
    Abdel-Bary AS; Tolan DA; Nassar MY; Taketsugu T; El-Nahas AM
    Int J Biol Macromol; 2020 Jul; 154():621-633. PubMed ID: 32179117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds.
    Ardeshirzadeh B; Anaraki NA; Irani M; Rad LR; Shamshiri S
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():384-90. PubMed ID: 25579938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.
    Xu SS; Wu J; Jiang W
    J Microencapsul; 2015; 32(6):533-7. PubMed ID: 26289219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites.
    Liu B; Yang W; Che C; Liu J; Si M; Gong Z; Gao R; Yang G
    ChemistryOpen; 2021 Apr; 10(4):408-413. PubMed ID: 33605540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
    Javanbakht S; Pooresmaeil M; Namazi H
    Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
    Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid conjugated poly (Amidoamine) dendrimer grafted magnetic chitosan as a smart drug delivery platform for doxorubicin: In-vitro drug release and cytotoxicity studies.
    Soltany P; Miralinaghi M; Pajoum Shariati F
    Int J Biol Macromol; 2024 Feb; 257(Pt 1):127564. PubMed ID: 37865361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the pH-Sensitivity of the Graphene and Carbon Nanotube Based Nanomedicines in Smart Cancer Therapy by Grafting Trimetyl Chitosan.
    Khoshoei A; Ghasemy E; Poustchi F; Shahbazi MA; Maleki R
    Pharm Res; 2020 Aug; 37(8):160. PubMed ID: 32747991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.